Y Morishima

7.9k total citations
235 papers, 6.0k citations indexed

About

Y Morishima is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Y Morishima has authored 235 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Hematology, 64 papers in Cardiology and Cardiovascular Medicine and 47 papers in Immunology. Recurrent topics in Y Morishima's work include Hematopoietic Stem Cell Transplantation (61 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Blood Coagulation and Thrombosis Mechanisms (36 papers). Y Morishima is often cited by papers focused on Hematopoietic Stem Cell Transplantation (61 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Blood Coagulation and Thrombosis Mechanisms (36 papers). Y Morishima collaborates with scholars based in Japan, United States and Germany. Y Morishima's co-authors include Yasufumi Shirasaki, Hiromichi Takano, Yuko Honda, Janine Zieg, Roger J. Davis, Tamera Barrett, Richard A. Flavell, Yukiko Gotoh, Michael E. Greenberg and Y Kodera and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Y Morishima

226 papers receiving 5.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Y Morishima 2.5k 1.3k 1.1k 1.1k 950 235 6.0k
Paul F. Bray 3.3k 1.3× 613 0.5× 645 0.6× 2.0k 1.8× 2.9k 3.1× 175 8.8k
Arne Slungaard 1.8k 0.7× 2.4k 1.8× 1.5k 1.3× 1.1k 1.0× 178 0.2× 68 5.1k
Yoshiaki Tomiyama 3.6k 1.4× 2.0k 1.6× 909 0.8× 2.0k 1.8× 988 1.0× 275 8.3k
Zhenyu Li 1.9k 0.8× 1.0k 0.8× 503 0.5× 1.5k 1.4× 893 0.9× 119 4.7k
Rafał Pawliński 2.1k 0.9× 1.8k 1.4× 443 0.4× 2.2k 2.0× 696 0.7× 103 6.7k
Bernd Engelmann 1.7k 0.7× 1.6k 1.3× 310 0.3× 1.6k 1.5× 651 0.7× 69 5.7k
Wolfgang Bergmeier 3.4k 1.4× 1.5k 1.2× 494 0.4× 1.5k 1.4× 1.4k 1.5× 139 6.8k
Alison H. Goodall 2.0k 0.8× 792 0.6× 320 0.3× 1.2k 1.1× 1.6k 1.6× 153 6.1k
Xiaoping Du 3.4k 1.4× 1.2k 1.0× 452 0.4× 2.3k 2.1× 1.4k 1.5× 104 7.2k
Susan S. Smyth 1.1k 0.4× 1.2k 0.9× 416 0.4× 2.7k 2.5× 1.7k 1.8× 149 6.5k

Countries citing papers authored by Y Morishima

Since Specialization
Citations

This map shows the geographic impact of Y Morishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Morishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Morishima more than expected).

Fields of papers citing papers by Y Morishima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Morishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Morishima. The network helps show where Y Morishima may publish in the future.

Co-authorship network of co-authors of Y Morishima

This figure shows the co-authorship network connecting the top 25 collaborators of Y Morishima. A scholar is included among the top collaborators of Y Morishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Morishima. Y Morishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Shinya, Takeshi Yamashita, Masaharu Akao, et al.. (2024). Patient Outcomes in Very Elderly Patients With Non-Valvular Atrial Fibrillation　― ANAFIE Registry ―. Circulation Reports. 6(8). 283–293. 1 indexed citations
2.
Nakamura, Masato, Hiroshi Inoue, Takeshi Yamashita, et al.. (2024). Coronary events in elderly patients with non-valvular atrial fibrillation: a prespecified sub-analysis of the ANAFIE registry. Cardiovascular Intervention and Therapeutics. 39(2). 145–155. 2 indexed citations
3.
Hiasa, Ken‐ichi, Hiroshi Inoue, Takeshi Yamashita, et al.. (2024). Clinical Outcomes and Anticoagulation Therapy in Elderly Non-Valvular Atrial Fibrillation and Heart Failure Patients. ESC Heart Failure. 11(2). 902–913. 6 indexed citations
4.
Terauchi, Yasuo, Hiroshi Inoue, Takeshi Yamashita, et al.. (2023). Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study. Cardiovascular Diabetology. 22(1). 175–175. 3 indexed citations
5.
Akao, Masaharu, Hiroshi Inoue, Takeshi Yamashita, et al.. (2023). Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― ANAFIE Registry Sub-Analysis ―. Circulation Journal. 87(12). 1765–1774. 4 indexed citations
6.
Yamashita, Takeshi, Masaharu Akao, Hirotsugu Atarashi, et al.. (2023). Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation　― Results From the ANAFIE Registry ―. Circulation Journal. 87(7). 957–963. 5 indexed citations
7.
Akao, Masaharu, Takeshi Yamashita, Hirotsugu Atarashi, et al.. (2023). Comprehension of Nonvalvular Atrial Fibrillation and Anticoagulant Adherence in Elderly Patients in a Subcohort Study of the All Nippon Atrial Fibrillation in the Elderly Registry. The American Journal of Cardiology. 204. 159–167. 1 indexed citations
8.
Kario, Kazuomi, Naoyuki Hasebe, Ken Okumura, et al.. (2022). Home Blood Pressure Can Predict the Risk for Stroke/Bleeding Events in Elderly Patients With Nonvalvular Atrial Fibrillation From the ANAFIE Registry. Hypertension. 79(12). 2696–2705. 7 indexed citations
9.
Kida, Keisuke, Takeru Nabeta, Takaaki Shiono, et al.. (2022). D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban. Journal of Cardiology. 79(6). 759–767. 3 indexed citations
10.
Bleakley, Marie, Aiko Sato‐Otsubo, Hiroki Torikai, et al.. (2012). HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype. Tissue Antigens. 80(2). 119–125. 4 indexed citations
11.
Chihara, Dai, Keitaro Matsuo, Junya Kanda, et al.. (2011). Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case–control study in Japan. Annals of Oncology. 23(4). 1061–1066. 4 indexed citations
12.
Ohmachi, Ken, Kensei Tobinai, Yukio Kobayashi, et al.. (2011). Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809. Annals of Oncology. 22(6). 1382–1391. 25 indexed citations
13.
Fleischhauer, Katharina, E. Zino, Mari Malkki, et al.. (2009). Significant differences in outcome following unrelated donor HCT can be better predicted using an algorithm incorporating both allele and epitope level matching for HLA-DPB1. UCL Discovery (University College London). 1 indexed citations
14.
Furugohri, Taketoshi, K. Isobe, Yuko Honda, et al.. (2008). DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. Journal of Thrombosis and Haemostasis. 6(9). 1542–1549. 246 indexed citations
15.
Ogawa, Yoshihiro, T Hotta, Kensei Tobinai, et al.. (2005). Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma. Annals of Oncology. 17(2). 330–333. 6 indexed citations
16.
17.
Suzuki, Ritsuro, Makoto Murata, Masahiro Kami, et al.. (2001). AML M0.の明確なサブタイプである骨髄/NK前駆細胞急性白血病. Blood. 98(11). 460. 2 indexed citations
18.
Tashiro, Tsuguhiko, Hideo Yamamori, Naganori Hayashi, et al.. (1997). N-3 vs N-6 POLYUNSATURATED FATTY ACIDS (PUFA) IN CRITICAL ILLNESS. 31(3). 107–110.
19.
Ohno, R, Toshiyuki Kobayashi, Y Morishima, et al.. (1992). Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).. PubMed. 6 Suppl 2. 92–5. 12 indexed citations
20.
Kawashima, Koichiro, Y Morishima, Yoshiro Kato, et al.. (1978). Acute lymphoblastic leukaemia of the B-cell type refractory to intensive chemotherapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(3). 448–55. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul F. Bray Breakdown of academic impact, for papers by Arne Slungaard Breakdown of academic impact, for papers by Yoshiaki Tomiyama Breakdown of academic impact, for papers by Zhenyu Li Breakdown of academic impact, for papers by Rafał Pawliński Breakdown of academic impact, for papers by Bernd Engelmann Breakdown of academic impact, for papers by Wolfgang Bergmeier Breakdown of academic impact, for papers by Alison H. Goodall Breakdown of academic impact, for papers by Xiaoping Du Breakdown of academic impact, for papers by Susan S. Smyth
Rankless by CCL
2026